The largest database of trusted experimental protocols

4 protocols using calmodulin agarose

1

Purification and Characterization of CaMKII

Check if the same lab product or an alternative is used in the 5 most similar protocols
ATP, calmodulin, calmodulin-agarose, protease inhibitor cocktail, anti-α-CaMKII antibody, secondary antibody conjugates, PMSF (phenylmethylsulfonylfluoride) and DTT (dithiothreitol) were from Sigma Chemicals, USA. Phosphocellulose was from Whatman, UK. IPTG (Isopropylthiogalactoside) and glutathione sepharose 4B were from GE, USA. Pierce glutathione-agarose was from Thermo Fisher Scientific. Phospho-Thr286-α-CaMKII antibody, was either from Sigma-Aldrich or from Cell Signaling Technology. Oligonucleotides were obtained from SigmaGenosys, USA. Quikchange site directed mutagenesis kit was from Stratagene, USA. Nitrocellulose paper was from PALL Gelmann. [γ-32P]ATP was from Bhabha Atomic Research Centre, India. Anti-glutathione-S-transferase (GST) antibody was from Santacruz Biotechnology Inc., USA. Protein phosphatase 1 (PP1) was from New England Biolabs, USA. GST-CaMKIINα plasmid was a gift from Dr. P. Rangarajan, Department of Biochemistry, Indian Institute of Science, Bangalore, India.
+ Open protocol
+ Expand
2

Purification of FtsQ-RNC Constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
We purified FtsQ-RNC constructs as previously described [12 (link)]. These RNCs contained nascent chain based on 101 N-terminal residues of FtsQ. This RNC contained in addition to the His tag on the ribosome a calmodulin binding peptide for an additional affinity purification step. The specific stalling sequence motif SecM contained the FXXXXWIXXXXGIRAGP motif. Nascent chains were expressed for 2 h in JE28 cells containing his-tagged ribosomes [17 (link)] by addition of 2 g/L arabinose. Pelleted cells were lysed in 20 mM Tris (pH 7.6), 10 mM MgCl2, 150 mM KCl, and 30 mM NH4Cl in a homogenizer at low pressure (15–17 kPsi). Two subsequent affinity purifications with Ni-NTAagarose (Quiagen, Hilden, Germany) and calmodulin agarose (Sigma-Aldrich, St. Louis, MO, USA) served to first selectively purify ribosomes and second to select those ribosomes that contained a stalled nascent chain.
+ Open protocol
+ Expand
3

Yeast Synthetic Drop-out Media Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Yeast synthetic drop-out media supplement without leucine, yeast nitrogen base without amino acids, dextrose, polyoxyethylene 10 lauryl ether (C12E10), L-α-phosphatidylcholine type XVI-E (Sigma) from fresh egg yolk, brain extract (BE) Type I Folch Fraction I from bovine brain containing approximately (w/w) 10% PI, 50% PS, and other lipids, phosphodiesterase 3′, 5′ cyclic nucleotide activator (calmodulin) from bovine brain, calmodulin-agarose, ATP (disodium salt, vanadium-free), sodium dodecyl sulfate (SDS), and all other chemicals were obtained from Sigma.
+ Open protocol
+ Expand
4

Tau Aggregation Inhibition Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Phosphatidylcholine (PC) type XI-E from egg yolk, phosphatidylserine (PS), calmodulin-agarose, and methylene blue (MB) were obtained from Sigma. methylene blue was prepared as stock solution of 5 mg/mL (w/v) and made freshly for each separate experiment. Tau 441 was obtained from Enzo Life Sciences. Pig brains were obtained from a local slaughterhouse and human autopsy brain tissues (medium frontal gyrus, a brain region highly affected in AD) were supplied by the Netherlands Brain Bank (NBB, Netherlands Institute for Neuroscience, Amsterdam, Netherlands) and obtained from 8 neuropathologically confirmed AD patients (age 79 ± 2yr, Braak stage V/VI) and from 7 age-matched non-diseased control subjects. Procedures, information, and consent forms of the NBB have been approved by the Medical Ethics Committee of the Vrije Universiteit Amsterdam Medical Centre on 30 April 2009. The project identification code is Avila(537). Investigations using human tissues were carried out following the rules of the Declaration of Helsinki of 1975 (https://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki/), revised in 2013.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!